Literature DB >> 30862442

Interactions between cancer stem cells, immune system and some environmental components: Friends or foes?

Fatemeh Vahidian1, Pascal H G Duijf2, Elham Safarzadeh3, Afshin Derakhshani4, Amir Baghbanzadeh5, Behzad Baradaran6.   

Abstract

Cancer stem cells (CSCs) are a subgroup of tumor cells that are characterized by their tumor initiating capacity, low proliferation rate, self-renewal capacity, pluripotency and chemoresistance. The immune system, including innate and adaptive immune cells, plays pro-tumorigenic and anti-tumorigenic roles in cancer biology. Immunosurveillance often initially successfully eradicates tumor cells. However, following a phenomenon referred to as immunoediting, cancer cells may ultimately evade immune destruction, thus enabling tumor progression. Here, we review how CSCs both escape immune destruction and foster establishment of an immunosuppressive tumor microenvironment through intricate interactions with and recruitment of a broad range of immune cells, including natural killer (NK) cells, myeloid-derived suppressor cells (MDSCs), regulatory T cells (Tregs), tumor-associated macrophages (TAMs), cytotoxic T-lymphocytes (CTLs) and T helper (Th) cells. Further elucidation of CSC-immune cell interactions and the underlying signaling mechanisms will open up novel opportunities to improve cancer immunotherapy.
Copyright © 2019 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CSC-immune cells interaction; CSCs; Cancer; Immune system cells; Immunoediting; Immunosuppression

Mesh:

Year:  2019        PMID: 30862442     DOI: 10.1016/j.imlet.2019.03.004

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  19 in total

Review 1.  The role of the natural killer (NK) cell modulation in breast cancer incidence and progress.

Authors:  Ehsan Razeghian; Mahdis Chahar Kameh; Sepehr Shafiee; Farima Khalafi; Fehimeh Jafari; Mohammadali Asghari; Kiarash Kazemi; Saba Ilkhani; Siavash Shariatzadeh; Arvin Haj-Mirzaian
Journal:  Mol Biol Rep       Date:  2022-08-25       Impact factor: 2.742

Review 2.  Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells.

Authors:  Jean-François Rossi; Patrice Céballos; Zhao-Yang Lu
Journal:  Cancer Commun (Lond)       Date:  2019-06-14

3.  IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway.

Authors:  Chuan Zhang; Kun Ma; Wu-Yin Li
Journal:  J Cancer       Date:  2019-10-21       Impact factor: 4.207

4.  XIAOPI Formula Inhibits Breast Cancer Stem Cells via Suppressing Tumor-Associated Macrophages/C-X-C Motif Chemokine Ligand 1 Pathway.

Authors:  Shengqi Wang; Xiaoyan Liu; Renlun Huang; Yifeng Zheng; Neng Wang; Bowen Yang; Honglin Situ; Yi Lin; Zhiyu Wang
Journal:  Front Pharmacol       Date:  2019-11-15       Impact factor: 5.810

Review 5.  Proteases Regulate Cancer Stem Cell Properties and Remodel Their Microenvironment.

Authors:  Anamarija Habič; Metka Novak; Bernarda Majc; Tamara Lah Turnšek; Barbara Breznik
Journal:  J Histochem Cytochem       Date:  2021-07-26       Impact factor: 2.479

6.  Transcriptional and Microenvironmental Landscape of Macrophage Transition in Cancer: A Boolean Analysis.

Authors:  Ugo Avila-Ponce de León; Aarón Vázquez-Jiménez; Meztli Matadamas-Guzman; Rosana Pelayo; Osbaldo Resendis-Antonio
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

Review 7.  Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis.

Authors:  Veronica Veschi; Francesco Verona; Melania Lo Iacono; Caterina D'Accardo; Gaetana Porcelli; Alice Turdo; Miriam Gaggianesi; Stefano Forte; Dario Giuffrida; Lorenzo Memeo; Matilde Todaro
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-25       Impact factor: 5.555

8.  Mast Cells Are Directly Activated by Cancer Cell-Derived Extracellular Vesicles by a CD73- and Adenosine-Dependent Mechanism.

Authors:  Yaara Gorzalczany; Ofer Merimsky; Ronit Sagi-Eisenberg
Journal:  Transl Oncol       Date:  2019-09-04       Impact factor: 4.243

Review 9.  Influence of Innate Immunity on Cancer Cell Stemness.

Authors:  Anna Pastò; Francesca Maria Consonni; Antonio Sica
Journal:  Int J Mol Sci       Date:  2020-05-09       Impact factor: 5.923

Review 10.  The Interactions Between Cancer Stem Cells and the Innate Interferon Signaling Pathway.

Authors:  Laura Martin-Hijano; Bruno Sainz
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.